Evonile Pharma financial results announcements

Evonile Pharma Q2 FY27 Results: Net Loss of ₹77.5 Cr

Evonile Pharma posted a ₹775.4 million quarterly loss for September 2026 versus profit a quarter earlier. Exceptional items of ₹682.6 million drove the half-year pre-tax loss.

Key figure

Net loss ₹77.5 Cr

Novartis India Q1 FY27 Results: Net Profit ₹32.2 Cr, Up 16.7% YoY

Novartis India Ltd reported revenue from operations of ₹103.8 Cr (+18.6% YoY) and net profit of ₹32.2 Cr (+16.7% YoY) for Q1 FY27.

Key figure

Net profit ₹32.2 Cr · +16.7% YoY

Novartis India Q4 FY26 Results: Net Profit ₹25.2 Cr, Down 14.0% YoY

Novartis India Ltd reported revenue from operations of ₹90.5 Cr (+7.9% YoY) and net profit of ₹25.2 Cr (-14.0% YoY) for Q4 FY26.

Key figure

Net profit ₹25.2 Cr · -14.0% YoY

Novartis India Financial Results

Novartis India approved its audited financial results for the year ended March 31, 2026. The board declared an unmodified audit opinion, signaling stable financial reporting standards.

Novartis India Q3 FY26 Results: Net Profit ₹16.1 Cr, Down 36.6% YoY

Novartis India Ltd reported net profit of ₹16.1 Cr (-36.6% YoY) for Q3 FY26.

Key figure

Net profit ₹16.1 Cr · -36.6% YoY